Elevated levels of miR-146a are observed in T1D, where it targets inflammation-related genes like tumor necrosis factor receptor-associated factor 6 (TRAF6) and interleukin-1 receptor-associated kinase 1 (IRAK1), thereby amplifying the inflammatory response. This evidence concerns the gene IRAK1 and type 1 diabetes mellitus.